Abbott, Abbott Park, Ill, and Medica Corp, Bedford, Mass, announced today that they have entered into an exclusive agreement for the worldwide commercialization of the Cell-Dyn EasyCell Digital Cell Morphology System for use in hospitals and clinical laboratories. This system automates the location of white blood cells on a stained blood film and preclassifies them, improving the efficiency of the lab.
Under terms of the agreement, Medica will manufacture the system, and Abbott will have exclusive distribution rights, and will be responsible for sales, marketing and customer support.
Medica develops, manufactures and distributes a line of in-vitro diagnostic products for hospitals and clinical laboratories for electrolytes, blood gas, hematology and clinical chemistry. Medica’s blood analysis products are sold in over 120 countries.
